Introduction to the session: the trial headlines
The aim of the article is to capture the session at EuroPCR 2017 covering the PIONEER AF-PCI trial, communicate the analysis of the trialists, and report the views expressed in the interactive discussion. This article does not constitute an independent review of the topic by the authors.
Gilles Montalescot as co-chair (with Marco Valgimigli) introduced the session. In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) on anticoagulation, additional dual antiplatelet therapy (DAPT) may reduce the risk for stent thrombosis and ischaemic events but increases the risk of bleeding. ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com